Rojas-Salazar, Y.; Gómez-Montañez, E.; Rojas-Salazar, J.; de Anda-Jáuregui, G.; Hernández-Lemus, E.
Potential Drug Synergy Through the ERBB2 Pathway in HER2+ Breast Tumors. Int. J. Mol. Sci. 2024, 25, 12840.
https://doi.org/10.3390/ijms252312840
AMA Style
Rojas-Salazar Y, Gómez-Montañez E, Rojas-Salazar J, de Anda-Jáuregui G, Hernández-Lemus E.
Potential Drug Synergy Through the ERBB2 Pathway in HER2+ Breast Tumors. International Journal of Molecular Sciences. 2024; 25(23):12840.
https://doi.org/10.3390/ijms252312840
Chicago/Turabian Style
Rojas-Salazar, Yareli, Emiliano Gómez-Montañez, Jorge Rojas-Salazar, Guillermo de Anda-Jáuregui, and Enrique Hernández-Lemus.
2024. "Potential Drug Synergy Through the ERBB2 Pathway in HER2+ Breast Tumors" International Journal of Molecular Sciences 25, no. 23: 12840.
https://doi.org/10.3390/ijms252312840
APA Style
Rojas-Salazar, Y., Gómez-Montañez, E., Rojas-Salazar, J., de Anda-Jáuregui, G., & Hernández-Lemus, E.
(2024). Potential Drug Synergy Through the ERBB2 Pathway in HER2+ Breast Tumors. International Journal of Molecular Sciences, 25(23), 12840.
https://doi.org/10.3390/ijms252312840